State of Science Summit- GI Cancers: Chaired by Daneng Li, MD

Commentary
Article

In Partnership With:

State of Science Summit- GI Cancers: Chaired by Daneng Li, MD

State of Science Summit- GI Cancers: Chaired by Daneng Li, MD

Speakers

  • Afsaneh Barzi, MD, PhD | City of Hope
  • Vincent Chung, MD | City of Hope
  • Marwan Fakih, MD | City of Hope
  • Richard T. Lee, MD | City of Hope

Topics

  • Role of HER2 in Patients with CRC
  • Managing Pancreatic Cancer
  • Updates in Gastroesophageal cancer
  • Updates in Hepatocellular Carcinoma (HCC)
  • Emerging Targets in Colorectal Cancer
  • Updates in Advanced Biliary Tract Cancer

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Alexey Danilov, MD, PhD, an expert on mantle cell lymphoma
In this sixth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss potential opportunities to leverage artificial intelligence tools in cancer screening, diagnosis, staging, and prognosis.
A panel of 6 experts on breast, lung, and gastrointestinal cancers
In this fifth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss the need for evidence to support the utilization of different artificial intelligence tools in healthcare.
Maurie Markman, MD
A panel of 6 experts on breast, lung, and gastrointestinal cancers
A panel of 6 experts on breast, lung, and gastrointestinal cancers
Haejin In, MD, MPH, MBA, FACS, FSSO
In this fourth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, explain the importance of having a diverse editorial board behind a new journal on artificial intelligence in precision oncology.
A panel of 6 experts on breast, lung, and gastrointestinal cancers